Global Longlife Hospital and Research Ltd
₹ 10.5
0.19%
16 Jun
2:36 p.m.
About
Incorporated in 2015, Global Longlife Hospital & Research Ltd is in the business of Health Care and Hospitals[1]
Key Points
- Market Cap ₹ 11.0 Cr.
- Current Price ₹ 10.5
- High / Low ₹ 28.0 / 10.3
- Stock P/E
- Book Value ₹ 22.6
- Dividend Yield 0.00 %
- ROCE -3.92 %
- ROE -6.81 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Stock is trading at 0.46 times its book value
Cons
- Company has low interest coverage ratio.
- Promoter holding has decreased over last quarter: -12.6%
- Promoter holding is low: 22.9%
- Company has a low return on equity of -8.85% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Loading peers table ...
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| 33.44 | 33.32 | 32.70 | 32.44 | 23.38 | 13.46 | 0.31 | 0.00 | |
| 26.61 | 29.88 | 27.26 | 24.14 | 19.30 | 13.68 | 4.45 | 1.00 | |
| Operating Profit | 6.83 | 3.44 | 5.44 | 8.30 | 4.08 | -0.22 | -4.14 | -1.00 |
| OPM % | 20.42% | 10.32% | 16.64% | 25.59% | 17.45% | -1.63% | -1,335.48% | |
| 0.08 | 0.03 | 0.06 | 0.17 | 0.24 | 0.00 | 5.02 | 0.01 | |
| Interest | 2.07 | 2.41 | 2.44 | 1.62 | 0.45 | 0.80 | 0.30 | 0.00 |
| Depreciation | 2.15 | 2.13 | 1.31 | 1.14 | 1.17 | 1.25 | 0.48 | 0.00 |
| Profit before tax | 2.69 | -1.07 | 1.75 | 5.71 | 2.70 | -2.27 | 0.10 | -0.99 |
| Tax % | 49.07% | -18.69% | -16.57% | 37.30% | 32.59% | -3.52% | -100.00% | 73.74% |
| 1.36 | -0.86 | 2.05 | 3.57 | 1.83 | -2.19 | 0.20 | -1.72 | |
| EPS in Rs | 1.94 | -1.23 | 2.93 | 5.10 | 1.74 | -2.09 | 0.19 | -1.64 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -100% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 63% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -37% |
| 1 Year: | -63% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | -2% |
| 3 Years: | -9% |
| Last Year: | -7% |
Balance Sheet
Figures in Rs. Crores
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 7.00 | 7.00 | 7.00 | 7.00 | 10.50 | 10.50 | 10.50 | 10.50 |
| Reserves | 5.35 | 4.49 | 6.68 | 9.96 | 53.79 | 15.43 | 16.29 | 13.25 |
| 27.18 | 23.51 | 17.04 | 8.69 | 9.29 | 12.74 | 0.00 | 0.00 | |
| 3.77 | 6.92 | 6.06 | 8.33 | 2.36 | 3.07 | 0.06 | 0.01 | |
| Total Liabilities | 43.30 | 41.92 | 36.78 | 33.98 | 75.94 | 41.74 | 26.85 | 23.76 |
| 20.17 | 18.72 | 17.46 | 16.71 | 16.52 | 17.27 | 0.00 | 0.00 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 1.03 | 0.00 | 0.00 | 0.00 |
| Investments | 0.10 | 0.10 | 0.47 | 0.10 | 0.10 | 0.03 | 0.03 | 0.00 |
| 23.03 | 23.10 | 18.85 | 17.17 | 58.29 | 24.44 | 26.82 | 23.76 | |
| Total Assets | 43.30 | 41.92 | 36.78 | 33.98 | 75.94 | 41.74 | 26.85 | 23.76 |
Cash Flows
Figures in Rs. Crores
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| 5.40 | 3.90 | 6.88 | 9.42 | -40.42 | -5.07 | 12.32 | -4.51 | |
| -0.33 | -0.04 | 0.02 | 0.01 | -1.90 | -0.82 | 21.80 | 0.04 | |
| -4.77 | -3.05 | -7.22 | -9.66 | 45.70 | 2.67 | -13.01 | 0.00 | |
| Net Cash Flow | 0.31 | 0.81 | -0.33 | -0.22 | 3.38 | -3.22 | 21.11 | -4.47 |
| Free Cash Flow | 5.00 | 3.79 | 6.84 | 8.96 | -42.42 | -6.10 | 33.42 | -4.51 |
| CFO/OP | 79% | 113% | 126% | 105% | -960% | 2,259% | -304% | 401% |
Ratios
Figures in Rs. Crores
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 94.85 | 68.68 | 87.51 | 100.25 | 151.43 | 52.88 | 376.77 | |
| Inventory Days | 169.49 | 157.97 | 34.46 | 88.98 | 69.12 | 131.64 | 0.00 | |
| Days Payable | 229.91 | 391.69 | 138.68 | 432.74 | 110.43 | 765.90 | ||
| Cash Conversion Cycle | 34.44 | -165.03 | -16.71 | -243.52 | 110.13 | -581.38 | 376.77 | |
| Working Capital Days | 19.21 | 12.16 | 7.14 | -29.70 | 344.86 | -238.36 | 1,283.39 | |
| ROCE % | 3.81% | 12.75% | 26.22% | 6.35% | -2.51% | -13.69% | -3.92% |
Insights
In beta| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Total Permanent Employees Number |
|
||||
| Solar Power Plant Capacity KW |
|||||
| Total Bed Capacity Beds |
|||||
Requires Premium
Requires Premium
Extracted by Screener AI
Documents
Announcements
-
Reg. 34 (1) Annual Report.
2 Jun - FY2025-26 annual report filed; AGM on June 25, 2026 to approve name, object changes and director reappointments.
-
Notice Of 15Th Annual General Meeting Of The Company To Be Held On June 25, 2026 At 11:00 AM IST Through VC/OAVM.
2 Jun - 15th AGM on June 25, 2026; proposes name change, object-clause alteration, and MD reappointment.
-
Announcement under Regulation 30 (LODR)-Change in Management
30 May - Board approved re-appointment of Independent Director Manasvi Manu Thapar for 2026-2031, subject to shareholder approval.
-
Announcement under Regulation 30 (LODR)-Change in Management
30 May - Board approved Dhruv Jani's reappointment as Managing Director for five years from Sept 10, 2026, subject to shareholder approval.
-
Announcement under Regulation 30 (LODR)-Change in Management
30 May - Board appointed M/s Insiya Nalawala & Associates as Secretarial Auditor for FY 2026-27 on May 30, 2026.
Business Overview[1]
The company operates a multi-specialty tertiary care hospital in Gujarat, providing infrastructure and clinical support for a broad range of medical and surgical specialties. It follows an open-doctor model, allowing qualified doctors with 3+ years of experience to admit and treat patients at the hospital.